Home
News
Screeners
Insights
Zenith Health Care
3.
12
-0.01
(-0.32%)
Market Cap
₹16.75 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.32%
1M
+0.97%
6M
-8.77%
1Y
-22.39%
5Y
-61.34%
View Company Insights
Latest news about Zenith Health Care
Zenith Health Care files 32nd annual report with BSE under SEBI rules
13 mins ago
Today
Zenith Health Care Limited filed its 32nd Annual Report with the BSE on August 4, 2026, adhering to SEBI LODR Regulation 34. The submission was signed by Joint Managing Director Akshit M. Raycha, ensuring compliance with mandatory disclosure norms for listed entities.
Zenith Health Care seeks approval for ₹100 crore related-party deal at AGM
39 mins ago
Today
Zenith Health Care approves amalgamation with Achyut Healthcare
Jul 15, 2026
Zenith Healthcare FY26 profit falls, appoints auditor
May 29, 2026
Zenith Healthcare Limited Declares Non-Applicability of Large Corporate Disclosure Requirements for FY26
Apr 11, 2026
More news about Zenith Health Care
11
Apr 26
Zenith Healthcare Limited Submits RTA Declaration for Quarter Ended March 31, 2026
Zenith Healthcare Limited filed its quarterly RTA declaration under Regulation 74(5) of Depositories and Participants Regulations 2018 for Q4 FY26 ended March 31, 2026. The company submitted the mandatory compliance document to BSE on April 11, 2026, along with a certificate from Bigshare Services Private Limited confirming proper handling of dematerialization processes and compliance with regulatory requirements.
12
Feb 26
Zenith Healthcare Reports Strong Q3FY26 Turnaround with ₹22.41 Lakh Net Profit
Zenith Healthcare Limited reported a strong financial turnaround in Q3FY26 with net profit of ₹22.41 lakh compared to a loss of ₹29.22 lakh in Q3FY25. Revenue from operations increased to ₹248.30 lakh, while the nine-month period showed net profit of ₹34.71 lakh against previous year's loss of ₹4.27 lakh. The company demonstrated improved operational efficiency with reduced material costs and positive earnings per share of ₹0.042.
11
Nov 25
Zenith Healthcare Reports Mixed Q2 Results with Revenue Dip, Profit Growth for H1 FY2026
Zenith Healthcare Limited released its Q2 FY2026 results, showing a 9.6% quarter-on-quarter decline in revenue to ₹302.79 crore and a 9.5% drop in net profit to ₹21.88 crore. However, half-yearly results were more positive, with H1 FY2026 revenue increasing 14% year-over-year to ₹638.58 crore and net profit surging 70.9% to ₹39.34 crore. The company's balance sheet remains strong with total equity of ₹752.92 lakh against total assets of ₹1,072.03 lakh. The Board approved these results on November 11, 2025.
Zenith Health Care
3.
12
-
0.
01
(-
0.
32
%)
1 Year Returns:
-22.39%
Industry Peers
Sun Pharmaceutical
1,957.50
(-
0.
31
%)
Divis Laboratories
8,350.50
(-
2.
73
%)
Torrent Pharmaceuticals
5,016.50
(-
0.
66
%)
Cipla
1,450.70
(-
1.
61
%)
Zydus Life Science
1,117.60
(-
0.
30
%)
Lupin
2,388.00
(-
0.
21
%)
Mankind Pharma
2,451.60
(-
1.
26
%)
Laurus Labs
1,834.30
(+
1.
26
%)
Dr Reddys Laboratories
1,160.10
(-
1.
69
%)
Aurobindo Pharma
1,568.20
(+
0.
87
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar